(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ETOLOCE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ETOLOCE

ST13

US500000098240030

Class

5

Filing

98240030

Registration

7638977

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

15

Latest update

01/07/2025

Trademark type

Word

Nice classes

5

Filing date

10/25/2023

Registration date

01/07/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/07/2025

Last transaction

01/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

Yeonsu-gu, Incheon, KR

Examiner

RUTLAND, BARBARA A

Law office

L10

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Samsung Bioepis Co., Ltd.

Representatives

Stephen R. Barrese DILWORTH & BARRESE, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for medical usepharmaceutical preparations for immunoregulationfor treatment of autoimmune diseasesfor use as anti-cancer agentsfor treatment of cancerfor treatment of tumorsfor treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for the treatment of immune system related diseases; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of ankylosing spondylitis; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for the treatment of enthesitis-related arthritis

Publications

History of USPTO decisions and trademark events.

15 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/07/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/17/2024

PUBO

PUBLISHED FOR OPPOSITION

09/17/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/28/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/15/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/14/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/14/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/14/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/16/2024

GNRT

NON-FINAL ACTION E-MAILED

06/16/2024

CNRT

NON-FINAL ACTION WRITTEN

06/16/2024

DOCK

ASSIGNED TO EXAMINER

06/07/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/31/2023

NWAP

NEW APPLICATION ENTERED

10/28/2023

Continuous trademark protection

Get notified about every new filing that threatens ETOLOCE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.